The Economic Times
English EditionEnglish Editionहिन्दी
| E-Paper
Search
+

    Buy Sun Pharma, target price Rs 620: Motilal Oswal

    Synopsis

    Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 141668.73 Crore) operating in Pharmaceuticals sector.

    Agencies
    Promoters held 54.7 per cent stake in the company as of Sept 30, 2020, while FIIs held 12.4 per cent, DIIs 20.5 per cent and public and others 12.5 per cent.

    INSIGHTS

    Read Stock Insights by ET for a quick analysis

    Explore Now
    Motilal Oswal has buy call on Sun Pharmaceutical Industries with a target price of Rs 620.
    The current market price of Sun Pharmaceutical Industries Ltd. is Rs 595.

    Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 141668.73 Crore) operating in Pharmaceuticals sector.

    Financials
    For the quarter ended 30-09-2020, the company reported a Consolidated sales of Rs 8458.77 Crore, up 13.28 % from last quarter Sales of Rs 7467.19 Crore and up 6.41 % from last year same quarter Sales of Rs 7949.19 Crore. Company reported net profit after tax of Rs 1948.38 Crore in latest quarter.

    Investment Rationale
    Consolidation breakout above 585 zones with recent highest daily close

    Promoter/FII Holdings
    Promoters held 54.7 per cent stake in the company as of Sept 30, 2020, while FIIs held 12.4 per cent, DIIs 20.5 per cent and public and others 12.5 per cent.
    (What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    Also Read

    Read before you invest. Insights on Sun Pharmaceutical Industries Ltd.. Explore Now
    The Economic Times